Literature DB >> 23403412

Semantic association fMRI impairments represent a potential schizophrenia biomarker.

Sharna D Jamadar1, Godfrey D Pearlson, Kasey M O'Neil, Michal Assaf.   

Abstract

Semantic association retrieval task (SORT) requires participants to indicate whether word pairs recall a third object, e.g. 'honey' and 'stings' activates 'bees'. We have previously shown that individuals with schizophrenia with more severe positive symptoms tend to report associations between unrelated word pairs than healthy controls; schizophrenia individuals with more severe negative symptoms tend to fail to report associations between related word pairs. This over-retrieval and under-retrieval on SORT correlates with functional magnetic resonance imaging (fMRI) activity in inferior parietal lobule (IPL). To examine the suitability of SORT as an endophenotype for schizophrenia, we examined SORT performance and activity across multiple stages of the illness: chronic, relapse, and first episode. We also examine SORT performance and activity in unaffected relatives. SORT performance and fMRI activity in schizophrenia-first episode, schizophrenia-chronic and schizophrenia-relapse were significantly impaired relative to healthy controls and unaffected relatives. Schizophrenia-chronic and schizophrenia-relapse participants showing more severe PANSS-positive and -general symptoms showed larger SORT impairments. For schizophrenia-first episode more severe negative symptoms were related to lower IPL activation, consistent with previous results showing that negative symptoms are among the first to emerge in the schizophrenia prodrome and that more severe symptoms in the first episode predict worse future outcomes. Unaffected relatives showed no impairments on SORT performance or fMRI activity relative to healthy controls, which is incompatible with the concept of SORT as an endophenotype for schizophrenia, but is consistent with the concept of SORT as a potential schizophrenia biomarker.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23403412      PMCID: PMC3732787          DOI: 10.1016/j.schres.2012.12.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  33 in total

1.  What is the best similarity measure for motion correction in fMRI time series?

Authors:  L Freire; A Roche; J F Mangin
Journal:  IEEE Trans Med Imaging       Date:  2002-05       Impact factor: 10.048

Review 2.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

3.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.

Authors:  A Jablensky; N Sartorius; G Ernberg; M Anker; A Korten; J E Cooper; R Day; A Bertelsen
Journal:  Psychol Med Monogr Suppl       Date:  1992

4.  Parietal lobe volume deficits in schizophrenia spectrum disorders.

Authors:  Shi-Yu Zhou; Michio Suzuki; Tsutomu Takahashi; Hirofumi Hagino; Yasuhiro Kawasaki; Mie Matsui; Hikaru Seto; Masayoshi Kurachi
Journal:  Schizophr Res       Date:  2006-10-24       Impact factor: 4.939

Review 5.  Visual feature integration and the temporal correlation hypothesis.

Authors:  W Singer; C M Gray
Journal:  Annu Rev Neurosci       Date:  1995       Impact factor: 12.449

6.  Abnormal object recall and anterior cingulate overactivation correlate with formal thought disorder in schizophrenia.

Authors:  Michal Assaf; Paul R Rivkin; Cheedem H Kuzu; Vince D Calhoun; Michael A Kraut; Karyn M Groth; Michael A Yassa; John Hart; Godfrey D Pearlson
Journal:  Biol Psychiatry       Date:  2005-09-30       Impact factor: 13.382

7.  Genetic influences of cortical gray matter in language-related regions in healthy controls and schizophrenia.

Authors:  S Jamadar; N R Powers; S A Meda; J Gelernter; J R Gruen; G D Pearlson
Journal:  Schizophr Res       Date:  2011-04-20       Impact factor: 4.939

8.  Language in schizophrenia Part 2: What can psycholinguistics bring to the study of schizophrenia...and vice versa?

Authors:  Gina R Kuperberg
Journal:  Lang Linguist Compass       Date:  2010-08-01

9.  Impairment in semantic retrieval is associated with symptoms in schizophrenia but not bipolar disorder.

Authors:  Sharna Jamadar; Kasey M O'Neil; Godfrey D Pearlson; Mahvesh Ansari; Adrienne Gill; Kanchana Jagannathan; Michal Assaf
Journal:  Biol Psychiatry       Date:  2012-09-15       Impact factor: 13.382

10.  The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy.

Authors:  P F Liddle
Journal:  Br J Psychiatry       Date:  1987-08       Impact factor: 9.319

View more
  4 in total

1.  Disruptions in the left frontoparietal network underlie resting state endophenotypic markers in schizophrenia.

Authors:  George Chahine; Anja Richter; Sarah Wolter; Roberto Goya-Maldonado; Oliver Gruber
Journal:  Hum Brain Mapp       Date:  2016-12-23       Impact factor: 5.038

2.  Reduced functional connectivity during controlled semantic integration in schizophrenia: A multivariate approach.

Authors:  Todd S Woodward; Christine M Tipper; Alexander L Leung; Katie M Lavigne; Nicole Sanford; Paul D Metzak
Journal:  Hum Brain Mapp       Date:  2015-05-25       Impact factor: 5.038

3.  Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective.

Authors:  Dong-Jie Xie; Hai-Song Shi; Simon S Y Lui; Chuan Shi; Ying Li; Karen K Y Ho; Karen S Y Hung; Wen-Xiu Li; Zheng-Hui Yi; Eric F C Cheung; Ann M Kring; Raymond C K Chan
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

4.  Alteration of Semantic Networks during Swear Words Processing in Schizophrenia.

Authors:  Sang Won Lee; Bumseok Jeong; Jong-Il Park; Gyung Ho Chung; Hyo-Jong Lee; Yin Cui; Woo-Sung Kim; Kang Han Oh; Il Seok Oh; Guang Fan Shen; Young-Chul Chung
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-02-28       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.